Elaspine
Commercial- Indications
- Lumbar degenerative spine, Spinal stenosis, Spondylolisthesis
Company intelligence / Profile preview
Spinelab
Winterthur, Zurich canton, Switzerlandspinelab.co.uk ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Spinelab developed and commercialized Elaspine™, a CE-marked, pedicle screw-based spinal motion preservation system for degenerative lumbar spine disease. The product was unique for its biomechanical approach and minimally invasive options, with clinical performance documented in European studies and registries. The company is no longer active[2][4].
- Therapeutic areas
- Neurology
- Modalities
- DeviceImplantable medical device (spinal motion preservation system)
- Industry
- Implantable Medical Devices
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Spinelab.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Spinelab.